Investors

BioVie Inc. (ticker symbol: BIVI) is a clinical-stage company developing transformative therapies to overcome unmet medical needs in chronic debilitating diseases.

Biovie Stock : BIVI

Events and Presentations

BioVie KOL Webinar: Complications of Advanced Liver Cirrhosis and BIV201 Phase 2b Clinical Trial Update

Thursday, November 11th from 1:00 - 2:30 PM EDT
REPLAY

BioVie KOL Webinar on Neuroinflammation and Insulin Resistance and NewTreatment Approaches for Alzheimer's Disease (AD)

Tuesday, October 26th from 1:30 - 3:00 PM EDT
Click here to replay event

NE3107 Featured in the American Diabetes Association's Thought Leadership Film Series

Watch: NE3107 Featured at the ADA

BioVie interview on Bloomberg Television US on the RedChip Money Report®

Watch the interview with Cuong Do here

BioVie hosting Research & Development Day

Wednesday, May 19th, 2021, from 12:00pm – 2:00pm Eastern Time

Watch the replay here: <http://media.rampard.com/20210519>
(You'll need your registration info)

REPLAY

Press Releases

SEC Filings

Forward Looking Statements
This website contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that involve risks, uncertainties, and assumptions that could cause BioVie’s actual results and experience to differ materially from anticipated results and expectations expressed in these forward-looking statements.
MORE
Sign-up to follow our progress
* indicates required
9120 Double Diamond Parkway
Suite 1400
Reno, NV 89521
(775) 888-3162

Email: info@biovieinc.com
Web: www.bioviepharma.com
© Copyright 2012 - 2021 | BioVie Inc. | ALL RIGHTS RESERVED |
 SITE MAP |
  PRIVACY POLICY |